BRTX — Biorestorative Therapies Cashflow Statement
0.000.00%
Last trade - 00:00- $6.13m
- $3.19m
- $0.36m
Annual cashflow statement for Biorestorative Therapies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -44.3 | -18.5 | -10.4 | -8.98 | -14.2 |
| Depreciation | |||||
| Non-Cash Items | 40.6 | 12.4 | 3.31 | 0.531 | 1.93 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.325 | 0.014 | 0.515 | 0.029 | 1.31 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -3.33 | -5.91 | -6.43 | -8.23 | -10.8 |
| Capital Expenditures | -0.031 | -0.44 | -0.171 | -0.106 | -0.116 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -13 | 3.42 | 0.621 | 9.01 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.031 | -13.4 | 3.25 | 0.515 | 8.9 |
| Financing Cash Flow Items | 0 | — | — | -0.149 | -0.283 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 21.3 | — | 2.35 | 7.38 | 2.85 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 18 | -19.3 | -0.829 | -0.336 | 0.963 |